Outcome of Fetal Spina Bifida
Neural tube defects are one of the most prevalent congenital abnormalities, surpassed only by cardiac malformations. Spina bifida accounts for the majority of the neural tube defects and is comprised of a wide spectrum of anomalies ranging from small isolated sacral dysraphisms to large spinal defects. The origin of spina bifida is a failure of neurulation. It usually occurs at 15 days post-conception, resulting in a bony spinal defect with extrusion of the neural placode and/or the meninges outside of the spinal canal. Spina bifida has a prevalence of 1-5 in 1,000 live births and is the most complex congenital abnormality compatible to long-time survival. Concerning psychomotor development as well as urinary bladder and intestinal morbidity the prognosis ranges from normal functional outcome to severe disability.
The diagnosis of serious fetal abnormalities such as spinal dysraphism by ultrasound screening allows patients to prepare for the birth of an impaired child or to consider termination of the pregnancy. In current practice, prenatal counseling and obstetric management depend not only on the detection of a spinal dysraphism but also on an appropriate assessment of the severity of the defect and its possible impact on the postnatal development of the affected child.
Level and type of lesion, presence of associated anomalies (e.g., Chiari II malformation and ventriculomegaly) and mode of surgical closure are factors known to have prognostic impact on the postnatal outcome. Previous studies reported that postnatally determined lesion levels correlated well with functional status and survival. On the contrary, it is still not clear whether similar data obtained antenatally are of value.
In this study, the investigators will review their database of all cases of prenatally diagnosed spina bifida within a 16 year period between 1993 and 2009. By analyzing the prenatal and postnatal characteristics of fetuses with spina bifida in relation to the anatomic level of the lesion, the investigators aim to contribute further information regarding the natural course of affected pregnancies and the correlation of prenatal ultrasound findings with their functional outcome.
Fetal and Neonatal Health
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Fetal Spina Bifida -Prenatal Course and Outcome in 103 Cases A Single Center Experience.|
- pregnancy outcome [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]To investigate the prenatal course and functional outcome of fetuses with spina bifida according to prenatal ultrasound exam.
- Infant psychomotor development [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]
Denver Developmental Screening Test
- Infant bladder and bowel function [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]Degree of continence.
- Conception date [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]
- spectrum of ultrasound signs [ Time Frame: 17yrs ] [ Designated as safety issue: No ]
|Study Start Date:||December 2009|
|Estimated Primary Completion Date:||October 2014 (Final data collection date for primary outcome measure)|
spinal lesion at thoracal level detected at prenatal ultrasound exam
spinal lesion at lumbar level detected at prenatal ultrasound exam
spinal lesion at sacral level detected at prenatal ultrasound exam
Please refer to this study by its ClinicalTrials.gov identifier: NCT01100697
|Contact: Feriel Amari, M.D.||+49 451 500 email@example.com|
|Contact: Klaus Diedrich, PhD||+49 451 500 firstname.lastname@example.org|
|Schleswig- Holstein University, Campus Lübeck, Department of Prenatal Medicine||Recruiting|
|Lübeck, Schleswig- Holstein, Germany, D- 23538|
|Contact: Feriel Amari, M.D. + 49 451 989 2663 email@example.com|
|Sub-Investigator: Daniel Beyer, M.D.|
|Sub-Investigator: David Hartge, M.D.|
|Sub-Investigator: Martin Krapp, PhD|
|Sub-Investigator: Ute Germer, PhD|
|Sub-Investigator: Ulrich Gembruch, PhD|
|Sub-Investigator: Roland Axt-Fliedner, PhD|
|Principal Investigator: Jan Weichert, M.D.|
|Principal Investigator: Feriel Amari, M.D.|
|Principal Investigator:||Feriel Amari, M.D.||Schleswig- Holstein University, Lübeck|
|Study Director:||Jan Weichert, M.D.||Schleswig- Holstein University, Lübeck|
|Study Chair:||Klaus Diedrich, PhD||Schleswig- Holstein University, Lübeck|